Back
Protagonist Therapeutics Vs. Bel Fuse Industry Stock Comparison
Buy
53
PTGX
Protagonist Therapeutics
Last Price:
47.33
Seasonality Move:
0.57%
Buy
76
BELFB
Bel Fuse
Last Price:
79.92
Seasonality Move:
13.94%
Buy
53
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $45.92. The Score for PTGX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
76
Bel Fuse (BELFB)
is a Buy
Is Bel Fuse a Buy, Sell or Hold?
- The current Bel Fuse [BELFB] share price is $81.03. The Score for BELFB is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
- BELFB is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $45.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.
PTGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.63 | Buy |
Relative Strength Index (14 RSI): | 64.66 | Buy |
Chaikin Money Flow: | 83958 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.23 - 44.95) | Buy |
Bollinger Bands (100): | (30.04 - 41.4) | Buy |
BELFB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.86 | Buy |
Relative Strength Index (14 RSI): | 77.85 | Buy |
Chaikin Money Flow: | 207452 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (63.15 - 69.97) | Buy |
Bollinger Bands (100): | (62.12 - 69.5) | Buy |
PTGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.52 | Buy |
20-day SMA: | 43.52 | Buy |
50-day SMA: | 40.46 | Buy |
200-day SMA: | 30.86 | Buy |
8-day EMA: | 45.13 | Buy |
20-day EMA: | 43.68 | Buy |
50-day EMA: | 40.65 | Buy |
200-day EMA: | 32.21 | Buy |
BELFB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 69.56 | Buy |
20-day SMA: | 66.99 | Buy |
50-day SMA: | 67.04 | Buy |
200-day SMA: | 63.64 | Buy |
8-day EMA: | 70.81 | Buy |
20-day EMA: | 68.04 | Buy |
50-day EMA: | 66.68 | Buy |
200-day EMA: | 62.24 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.05 per share, an increase this year of $4.12 per share, and a decrease next year of $2.79 per share.
Bel Fuse Earnings Growth & BELFB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.53 per share, an increase next quarter of $0.66 per share, a decrease this year of $1.89 per share, and an increase next year of $0.28 per share.
Protagonist Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bel Fuse Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |